Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
exclusives
1 min read • April 17, 2024
From Benzinga’s Cannabis Capital Conference: CCELL CMO Angela Pih Says We’re Going To Make Sure Smoking Experience Quality Of Specification Of Partners In Brands Need
1 min read • April 17, 2024
From Benzinga’s Cannabis Capital Conference: MariMed CCO Howard Schacter Says Consistency Of Actual Product Is Difficult; Importance Of Investing In Having Traveling Training Team, Kitchen And Operations; Delivering Same Product If Not Packaging
1 min read • April 17, 2024
From Benzinga’s Cannabis Capital Conference: Kiva Confections Co-Founder And President Kristi Palmer Says Some Challenges Have Been Maintaining Unified Brand; New Jersey For Tins Cannot Have Photos; We Dont Have Same Luxuries In NJ; Trying To Unify When Not Possible
1 min read • April 17, 2024
From Benzinga’s Cannabis Capital Conference: Unified Branding in a Fragmented Market Starts Now
1 min read • April 16, 2024
From Benzinga’s Capital Cannabis Conference: Charlie Bachtell CEO At Cresco Labs Says The Cannabis Industry Needs Access To Capital To Be Able To Growth
1 min read • April 16, 2024
Darren Weiss Says Cannabis Is A Made In America Industry; We Make, Design Product Here; Opportunity As Country; Folks See It As Health Opportunity; Hopefully See U.S. Change Course Soon
1 min read • April 16, 2024
Matt Darin Says There Is Different Cannabis Cultures In Europe; Finding More Believers In Cannabis Legislation
1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Verano President Darren Weiss Says We Are Part Of Global Supply Chain; Florida Market Alone Over Next Couple Years $3B; Over $100B Worldwide Over Next 6 Years
1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Gold Flora CEO Laurie Holcomb Says “We Are In A Knife Fight In California”; California Medical Market Since 1998; Gold Flora Built Own Supply Chain; Seed to Sail; Cultivate Manufacture Distribute; See Us Expand Hitting 66% Adj. Gross Margins In Market Very Difficult; Take Business Model And Move To Other States
1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: Curaleaf CEO Matt Darin Says We Made Move Into Europe Three Years Ago And Became Core Focus; Opportunity Internationally To Scale Global And Able To Import/Export Cannabis
1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: DEMECAN Co-Founder & Managing Director Constantin Von Der Groeben Says We’ve Reached Tipping Point In Germany; Expected It Way Earlier; Germany Market Of 84M People; Probably Role Model For Other European Countries And Hopefully The US
1 min read • April 16, 2024
From Benzinga’s Cannabis Capital Conference: How Cannabis Affects the World Economy: Insights from Top PubCos Begins Now
Latest Headlines
View All
5 min read • September 2, 2026
Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights
10 min read • September 2, 2026
Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround
3 min read • September 2, 2026
Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows
2 min read • September 2, 2026
UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share
7 min read • September 2, 2026
Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation
3 min read • September 1, 2026
Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed
8 min read • September 1, 2026
BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future
2 min read • September 1, 2026
House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown
3 min read • September 1, 2026
Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split
13 min read • September 1, 2026
Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal
6 min read • September 1, 2026
Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.
4 min read • August 31, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.